Cannon-Albright LA, Goldgar DE, Wright EC, Turco A, Jost M, Meyer LJ, Piepkorn M, Zone JJ, Skolnick MH.
(1990) Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome 1p36.  
Am J Hum Genetics. 46:912-918.

Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH.
(1991) Inheritance of Nevus Number and Size in Melanoma and Dysplastic Nevus Syndrome Kindreds.
Journal Natl Cancer Inst. 83:1726-1733.

Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM , Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Diaz MO, Kwiatkowski DJ, Piepkorn MW, Zone JJ, Skolnick MH.
(1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
Science. 258:1148-1152.

Cannon-Albright LA, Goldgar DE, Neuhausen S, Gruis NA, Anderson DE, Lewis CM, Jost M, Tran TD, Nguyen K, Kamb A, Weaver-Feldhaus J, Meyer LJ, Zone JJ, Skolnick MH.
(1994) Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171.
Genomics. 23:265-268.

Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, Harrison D, Anderson DE,  Zone JJ, Skolnick MH.
(1994) Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus.
Cancer Research. 54:6041-6044.

Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright L, Kamb A.
(1995)  Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.
Oncogene. 11:987-991.

Cannon-Albright LA, Kamb A, Skolnick M.
(1996) A review of inherited predisposition to melanoma.
Semin Oncol. Dec; 23(6)667-72.

Thomas A, Cannon-Albright L, Bansal A, Skolnick MH:
(1999) Familial associations between cancer sites.
Comput Biomed Res., Dec;32(6): 517-529.

Abkevich V, Camp NJ, Gutin A, Farnham JM, Cannon Albright LA, Thomas A:
(2001) A robust multipoint linkage statistic (TLOD) to map complex trait loci.
Genet Epidemiol 21 Suppl 1:S492-497.

Gutin A, Abkevich V, Camp NJ, Farnham JM, Cannon Albright LA, Thomas A:
(2001) Allelic association in large pedigrees.
Genet Epidemiol 21 Suppl 1: S571-575.

Camp NJ, Gutin A, Abkevich V, Farnham JM, Cannon Albright LA, Thomas A:
(2001) A new non-parametric linkage (NPL) statistic for mapping both qualitative and quantitative trait loci.
Genet Epidemiol 21Suppl 1:S461-466.

Florell SR, Boucher KM, Holden JA, Meyer LJ, Samlowski WE, Cannon-Albright LA, Zone JJ, and Leachman SA
(2002) Failure to Detect Differences in Proliferation Status of Nevi from CDKN2A Mutation Carriers and Non-Carriers.
J Invest Dermatol 118(2):386-7.

Florell SR, Boucher KM, Leachman SA, Azmi F, Harris RM, Malone JC, Martignoni G, Bowen GM, Gerwels JW, Hood AF
(2003) Histopathologic Recognition of Involved Margins of Lentigo Maligna Excised by Staged Excision: An Interobserver Comparison Study.
Arch Dermatol. 139(5):595-604.

Alexander A, Samlowski WE, Grossman D, Bruggers CS, Harris R, Zone JJ, Noyes RD, Bowen GM, Leachman SA
(2003) Metastatic Melanoma in Pregnancy: Risk of Transplacental Metastases in the Infant.
J Clin Oncol. 21(11):2179-86.

Parker J, Florell SR, Alexander A, DiSario JA, Shami PJ, Leachman SA
(2003) Pancreatic Carcinoma Surveillance in Patients with Familial Melanoma.
Arch Dermatol. 139(8):1019-1025

Hull C, Alexander A, Leachman SA
(2003) Pharmacogenetic Candidate Genes for Melanoma.
Pharmacogenomics 4(6):753-65

Florell SR, Schmidt SJ, Porter-Gill P, Albertine KH, Murphy KJ, McKinney CB, Boucher KM, Grossman D, Biddle DL, Clayton F, Layfield LJ, Leachman SA
(2003) Novel application of a fibrin cell block method to evaluate melanocytic cell populations.
Pigment Cell Res. 16(6):662-9

Alexander A, Harris RM, Grossman D, Bruggers CS, Leachman SA
(2003) Vulvar Melanoma: Diffuse Melanosis and Metastasis to the Placenta.
J Am Acad Dermatol. 50(2):293-8

Herron MD, Vanderhooft SL, Smock K, Zhou H, Leachman SA, Coffin C
(2004) Proliferative Nodules in Congenital Melanocytic Nevi: A Clinicopathologic and Immunohistochemical Analysis.
Am J Surg Pathol. (2004) 28(8):1017-1025.

Hansen CB, Wadge LM, Lowstutter K, Boucher K, Leachman SA
(2004) Clinical Genetic Testing for Melanoma.
Lancet Oncol. (2004) 5(5):314-9.

Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA
(2004) Longitudinal Assessment of the Nevus Phenotype in a Melanoma Kindred.
J Invest Dermatol. 123(3):576-82. Submitted for Publication or in Press:

Warters RL, Adamson PJ, Pond CD and Leachman SA.
(2004) Melanoma cells express elevated levels of phosphorylated H2AX histone foci. Relationship to chromosome instability.
J. Invest. Dermatol. (in press)

Call TR, Boucher K, Whiting B, Hart M, Newman K, Kinney A, Bowen G, Zone JJ, Branson D, Leachman SA
(2004) Motivating Factors for Attendance of Skin Cancer Screenings.
J Am Acad Dermatol. (in press)

Florell SR, Boucher KM, Astle J, Kerber R, Mineau G, Wiggins C, Noyes D, Tsodikov, A, Cannon Albright LA, Leachman SA.
(2004) Prognostic Factors and Survival in familial Melanoma.
Submitted.

Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, Wiggins C, Noyes RD, Tsodikov A, Cannon-Albright LA, Zone JJ, Samlowski WE, Leachman SA.
(2005) Population-based analysis of prognostic factors and survival in familial melanoma.
J Clin Oncol. 2005 Oct 1;23(28):7168-77.

Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Brinton JP, Leachman SA.
(2005). Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation.
J Invest Dermatol. 125:1310-1312.

Pho L, Grossman D, Leachman SA.
(2006) Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Curr Opin Oncol. 18(2):173-179.

Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA.
(2006) Population-based prevalence of CDKN2A mutations in Utah melanoma families.
J Invest Dermatol 126(3):660-666.

Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E; (2006) Melanoma Genetics Consortium (GenoMEL).
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Cancer Res. 15;66(20):9818-9828.

Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Cannon-Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis N, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang JMS, Leachman SA, Mackie RM, Magnusson V, Mann G, Newton-Bishop J, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Lund Melanoma Study Group and Melnoam Genetics Consortium GenoMEL
(2007) Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents.
J Med Genet. 44(2):99-106

Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA.
(2007). Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands.
J Invest Dermatol. 127(1):183-188

. Pho LN, Leachman SA.
(2007) Genetic Testing for Familial Melanoma: Is It Right for You?
Skin Cancer Found. Journal: 25:23-23

Florell SR., Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM., Samlowski WE, Zone JJ, Leachman SA.
(2008) Increased Melanocytic Nevi and Nevus Density in a G-34T CDKN2A/p16 Melanoma-prone Pedigree.
J Invest Dermatol. (in press)

Eliason M, Hansen C, Hart M, Chen WC, Bowen G, Florell S, Harris R, Cannon-Albright L, Swinyer L, Leachman SA.
(2007) Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Archives of Derm. 143(11): 1409-1412

Aspinwall LG, Leaf SL, Dola E, Kohlman W, Leachman SA.
(2008) CDKN2A/p16 Genetic Test Reporting Improves Early Detection Intentions and Practices in High-Risk Melanoma Families.
Cancer Epidemiology, Biomarkers & Prevention 17:1510-1519.